Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice
- PMID: 19660493
- DOI: 10.1016/j.pbb.2009.07.016
Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice
Abstract
We previously showed in female rats that administration of the cannabinoid CB1 receptor antagonist AM251 reduced energy intake by selectively decreasing consumption of a palatable dietary option in comparison to a standard maintenance chow. In the present study we sought to generalize these findings to mice. We presented 6 week old female C57Bl/6J mice with daily 8 h access to a sugar fat whip dietary option along with ad libitum access to moist chow. Mice were injected daily with either vehicle (equal parts polyethylene glycol and saline, 2 ml/kg) or one of three doses of AM251 (1, 3, or 10 mg/kg). Food intake and body weight were measured daily for 21 days. Although 8 h access to sugar fat whip did not induce overconsumption in female mice, AM251 reduced their energy intake and body weight in a dose-dependent manner. The decrease in energy intake occurred for both chow and sugar fat whip. This difference from results in rats suggests that the effect of AM251 on palatable food intake may only be evident in models that induce overconsumption and/or that rats and mice may react differently to CB1 receptor antagonists.
Similar articles
-
Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R67-75. doi: 10.1152/ajpregu.00150.2008. Epub 2008 Apr 30. Am J Physiol Regul Integr Comp Physiol. 2008. PMID: 18448611 Free PMC article.
-
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet.J Physiol Pharmacol. 2014 Aug;65(4):487-96. J Physiol Pharmacol. 2014. PMID: 25179081
-
Responses to the cannabinoid receptor-1 antagonist, AM251, are more robust with age and with high-fat feeding.J Endocrinol. 2009 Nov;203(2):281-90. doi: 10.1677/JOE-09-0210. Epub 2009 Aug 13. J Endocrinol. 2009. PMID: 19679649
-
Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.Physiol Behav. 2007 Jul 24;91(4):383-8. doi: 10.1016/j.physbeh.2007.04.013. Epub 2007 Apr 14. Physiol Behav. 2007. PMID: 17521686 Free PMC article. Review.
-
Sugar and fat--from genes to culture.J Nutr. 2003 Mar;133(3):829S-830S. doi: 10.1093/jn/133.3.829S. J Nutr. 2003. PMID: 12612161 Review. No abstract available.
Cited by
-
Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.Curr Neuropharmacol. 2016;14(2):118-42. doi: 10.2174/1570159x14666151109103147. Curr Neuropharmacol. 2016. PMID: 26549651 Free PMC article. Review.
-
Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury.Anesthesiology. 2014 Dec;121(6):1311-9. doi: 10.1097/ALN.0000000000000422. Anesthesiology. 2014. PMID: 25188001 Free PMC article.
-
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.Diabetes. 2010 Apr;59(4):1046-54. doi: 10.2337/db09-1336. Epub 2010 Jan 12. Diabetes. 2010. PMID: 20068137 Free PMC article.
-
The Use of Cannabidiol in Metabolic Syndrome-An Opportunity to Improve the Patient's Health or Much Ado about Nothing?J Clin Med. 2023 Jul 11;12(14):4620. doi: 10.3390/jcm12144620. J Clin Med. 2023. PMID: 37510734 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical